Mast Therapeutics (NYSEMKT:MSTX): stock was range-bound between the intraday low of $0.611 and the intraday high of $0.6773 after having opened at $0.64 on Wednesdays session. The stock's market capitalization is 137.89M, it has a 52-week low of 0.21 and a 52-week high of 0.71. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.
Juno Therapeutics Inc. (NASDAQ:JUNO) on September 7, 2016 announced that it will webcast its presentations at two investor conferences in September. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mast Therapeutics, Inc. with MarketBeat.com's FREE daily email newsletter.
The stock's price switched up 58.59% 20-Days Simple Moving Average, added 56.19% from 50-Days Simple Moving Average and positively 77.29% from 200 Days Simple Moving Average.
For the current week, the company shares have a recommendation consensus of Buy. On average, equities analysts forecast that Mast Therapeutics will post ($0.21) earnings per share for the current year. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.01.
Mast Therapeutics, Inc. (NYSEMKT:MSTX) now has P/E (Price to Earnings) ratio of 0 while the company's industry has 35.93 P/E and the sector P/E is 35.9. (NYSE:MSTX) is $2.75 while analysts mean recommendation is 1.80. 0 analysts have suggested "Sell" for the company.
On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. The average true range of the stock is observed at 0.05 and the relative strength index of the stock is recorded at 82.68. The stock touched 52-week High of $0.71 on Sep 6, 2016 and 52-week Low of $0.21 on Feb 10, 2016. The 12-month average price target stands at $3.33, marking a 412% upside from where the shares last closed. The stock hit its 52-week high price on 09/06/16, and 52-week low price on 02/10/16. Stock value has moved between $42.72 - 60.24 in last one year. Shares have risen 79.67% over the trailing six months. The stock has a weekly performance of 50.42 percent and is 54 percent year-to-date as of the recent close.
While taking a glance at financials, we can look at a number of key indicators. The company now has a Return on Equity (ROE) of -177.70%. 0 analysts have rated the company as a strong "Hold". Beta value of the stock stands at 0.37. LeMaitre Vascular, Inc. (NASDAQ:LMAT) quarterly performance is 39.50% while its price to sale ratio is 4.52 and price to book ratio is 4.62. Total debt to equity ratio of the company for most recent quarter is 0.76 whereas long term debt to equity ratio for most recent quarter is 0.00.